Byrna CFO Settles 2,313 RSUs Amid 75% YTD Share Decline, Reinforcing Routine Vesting Strategy

Insider Activity Highlights a Strategic Vesting Window

On May 5 2026, Chief Financial Officer Kearnes Laurilee settled 2,313 restricted stock units (RSUs) that had vested the day before. The transaction increased her holdings from 6,804 to 9,387 shares, reflecting a routine vesting schedule rather than a discretionary purchase. The settlement price of $5.53 per share matched the close price of $5.51, underscoring that the move was driven by contractual vesting rather than market timing. For the broader market, this activity signals that Byrna’s senior executives are continuing to accrue equity through the company’s standard RSU program, which has been a key tool in aligning management incentives with shareholder value.

Implications for Investors and Company Outlook

The RSU vesting does not materially shift the supply of shares or dilute existing owners, but it does provide a transparent view of the company’s compensation philosophy. Byrna’s share price has slumped nearly 75 % year‑to‑date, and the company’s 52‑week low sits just above $5.24, making current equity attractive to long‑term investors. However, the recent negative weekly and monthly trends suggest that market sentiment remains bearish. The modest social media sentiment (+10) and moderate buzz (10.56 %) indicate limited investor chatter, implying that the market may view these insider transactions as routine rather than a catalyst for upside.

Kearnes Laurilee: A Profile of Steady Vesting

Since early 2025, Laurilee has accumulated 18,210 RSUs in March and 6,939 RSUs in May, totaling 25,149 shares vested as of May 5. Her transaction history shows no cash purchases or sales of common stock, only the settlement of RSUs as they mature. This pattern suggests a long‑term commitment to Byrna’s business model and a preference for equity participation over short‑term trading. Compared to other insiders, Laurilee’s activity is moderate; for example, President Ganz Bryan has executed larger cash trades, while other executives have fewer RSU transactions. Laurilee’s consistent vesting reinforces her alignment with the company’s growth trajectory and the expectation that Byrna’s non‑lethal defense solutions will gain traction in an expanding market.

What Investors Should Watch

1. RSU Vesting Schedule – The company’s RSU program remains a key incentive mechanism; future vesting events could signal upcoming share dilutions if the company opts to issue new shares to satisfy the RSUs.
2. Fundamental Recovery – Byrna’s price earnings ratio of 14.72 is moderate for the aerospace & defense sector; a rebound would require stronger revenue growth or cost controls, especially given the current 74 % YTD decline.
3. Market Sentiment – With low buzz and neutral sentiment, the stock is unlikely to attract speculative trading unless a substantive corporate event (e.g., partnership or product launch) emerges.

Overall, Kearnes Laurilee’s recent RSU settlement reflects a continuation of the company’s vesting strategy rather than an aggressive market maneuver. For investors, the move reinforces confidence in Byrna’s internal equity plan while highlighting the need to monitor the company’s fundamental performance for a potential turnaround.